3 KiB
Lipid Triad
https://pubmed.ncbi.nlm.nih.gov/29241485/
"Many CVRF-free middle-aged individuals have atherosclerosis. LDL-C, even at levels currently considered normal, is independently associated with the presence and extent of early systemic atherosclerosis in the absence of major CVRFs. These findings support more effective LDL-C lowering for primordial prevention, even in individuals conventionally considered at optimal risk."
Lipid combos: https://pubmed.ncbi.nlm.nih.gov/25458651/
"Aside from isolated hypertriglyceridemia, low levels of HDL-C, high levels of LDL-C, and high levels of TG in any combination were associated with increased risk of CVD."
LMHR paper: https://pubmed.ncbi.nlm.nih.gov/35106434/
"These data suggest that, in contrast to the typical pattern of dyslipidemia, greater LDL cholesterol elevation on a CRD tends to occur in the context of otherwise low cardiometabolic risk."
LDL Bounty
Criteria
- HDL Cholesterol of 50 mg/dL or above (≥ 1.29 mmol/L)
- Triglycerides of 100 mg/dL or below (≤ 1.13 mmol/L)
- LDL Cholesterol of 130 mg/dL or above (≥ 3.36 mmol/L)
- Either high Coronary Heart Disease (CHD) or high Cardiovascular Disease (CVD) (see the section below)
- By “normal” and “non-treated“, I mean:
- No stratifying by specific genetics
- No stratifying by drugs (no drug studies)
- No stratifying by a particular illness in advance of the study. (duh!)
- In other words, just a generally broad group of people like Framingham Offspring or the Jeppesen study
- And here’s some fine print that should be obvious, but just in case…
- The study needs to be published in a reputable journal
- It has to be dated before this article was posted, of course
- The study needs to have at least 400 participants that are stratified by this criteria. (The two studies above have over 500)
- I’d prefer no unusual “modeling” or “adjustments” to alter the data too far from it’s original set. This one goes by the honor system — if you have such a study and it is clearly warranted, I can give it a pass.
"High" defined as greater than the average rates of CVD per age group in the American population.
Criticisms
- Vanishingly small population subset. Unreasonable to expect it to have been studied.
- If studied in the general population, they won't be keto, so translation to keto subjects may be dubious.
- The sheer weight of the evidence in favour of LDL's causal role in ASCVD cuts deeply against the notion that this population subset would be protected to begin with.
- Comparing this isolated cohort to the American general population is methodology that is beyond fringe, bordering on insane.
- Ultimately if this is taken to be an indication that LDL is fine in this particular context, it would qualify as an appeal to ignorance.
Hashtags
#lipidology #lipid_triad #LMHR #LDL #triglycerides #HDL #clowns #clownery #debate #debate_opponents